Title: CILIACELL SENSITIVE and CILIACELL CHILDREN: The Revolution Continues in Treating Sinusitis and Otitis
Subtitle: Discover the new formulations specifically designed for sensitive mucosa and paediatric patients
Introduction:
Building on the success of CILIACELL Adult in treating purulent sinusitis and otitis, Nevia Biotech's research team has developed two new targeted solutions. Welcome CILIACELL SENSITIVE, for adult patients with sensitive or compromised nasal mucosa, and CILIACELL CHILDREN, specifically formulated for patients aged 6 to 12. These are two innovative answers to precise clinical needs, maintaining over 90% efficacy and the unique, patented triple-action mechanism.
CILIACELL SENSITIVE: Power and Gentleness
Who is it for?
CILIACELL SENSITIVE is the ideal choice for adult patients who, besides suffering from purulent sinusitis or effusive otitis, have underlying conditions that make the mucosa more fragile:
-
Associated allergic and non-allergic rhinitis
-
Presence of nasal polyps or turbinate hypertrophy
-
History of frequent decongestant/vasoconstrictor spray use
Key Strengths:
-
Enhanced, Gentle Formula: Enriched with Cucurbitacins B-D-I-E from Ecballium elaterium, it ensures effective yet non-aggressive action.
-
Mucosa Protection: Decongests without damaging, breaking the cycle of inflammation and irritation.
-
Short Therapeutic Cycle: Visible results in 7-14 days.
CILIACELL CHILDREN: Effectiveness Tailored for Children
Who is it for?
Specifically for children aged 6 to 12, it is indicated for:
-
Paediatric purulent sinusitis (yellow-greenish secretions)
-
Otitis media with effusion, a common complication following acute otitis
Key Strengths:
-
Combined Actions: It doesn't just target the nasal cavity. It thins muco-purulent secretions even in the paranasal sinuses and helps unblock the Eustachian tubes.
-
Maximum Safety: Gentle formula, free from steroids or antibiotics, designed for short treatment cycles.
-
Ideal for Paediatric Compliance: The short treatment duration (7-14 days) makes it easy to manage.
The Shared Mechanism of Action: The Triple Scientific Action
Both products share the patented mechanism of action that makes them unique:
-
Mucolytic: Thins mucus-pus, making it easier to eliminate.
-
Muco-Kinetic: Reactivates the natural mucociliary transport, the airways' natural "broom".
-
Non-Damaging Decongestant: Reduces mucosal swelling by acting on fluid drainage, without risk of dependency or epithelial damage.
Why Choose CILIACELL vs Traditional Therapies?
-
Vs Antibiotics: Works mechanically, promoting the elimination of infectious agents without the risk of bacterial resistance.
-
Vs Corticosteroids: Physically removes the cause of inflammation (the mucus-pus), rather than suppressing the immune response.
-
Vs Decongestants: Provides relief from congestion without the risk of tachyphylaxis (dependency) or damage to the mucosa (rhinitis medicamentosa).
Conclusions
With the arrival of CILIACELL SENSITIVE and CILIACELL CHILDREN, Nevia Biotech completes its range dedicated to respiratory health, offering increasingly personalised, effective, and safe solutions. These medical devices represent a concrete advancement in the therapy of rhino-sinus and otological conditions, confirming the company's commitment to innovation serving people's wellbeing.
For further technical details, complete product sheets, and bibliographic references of clinical studies, please visit the dedicated section on our website [Link to the CILIACELL products page on the Nevia Biotech website].
CILIACELL SENSITIVE and CILIACELL CHILDREN are CE-marked medical devices. Read the instructions for use carefully. Do not exceed the recommended dose and treatment duration. If in doubt, consult your doctor or pharmacist.
